<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>CancerCompass Message Board: Nventa's Therapuetic Medication HspE7</title>
    <description>CancerCompass message board discussion started by herenow on 3/14/2008</description>
    <link>http://www.cancercompass.com/message-board/message/all,21993,0.htm</link>
    <pubDate>Thu, 04 Dec 2008 00:00:00 GMT</pubDate>
    <lastBuildDate>Thu, 04 Dec 2008 00:00:00 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Nventa's Therapuetic Medication HspE7</title>
      <description>I have been very excited by Roche&amp;#39;s news about its therapuetic vaccine, TG-4001 because it is having successful results at clearing up cervical dysplasia caused by HPV-16. But is anyone familiar with Stressgen/Nventa Biopharmaceutical&amp;#39;s HspE7? They are in clinical trial, right now, with a therapuetic vaccine designed to clear up HPV-caused diseases.It warms my heart to know there are companies out there actually interested in developing medication to treat HPV-caused disease rather than just focus on vaccinating children from getting infected. While I think protecting children from a deadly virus is critical, those of us who have been infected with HPV are at much higher risk. The current methods of partial amputation just aren&amp;#39;t good enough at protecting people&amp;#39;s lives for the long term.I&amp;#39;m also curious to know if there are any other companies out there developing therapuetic medication.</description>
      <author>herenow</author>
      <pubDate>Fri, 14 Mar 2008 00:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>